dPCR & qPCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical Application, Forensic Applications, Research Application), End-User - Global Forecast 2024-2030

dPCR & qPCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical Application, Forensic Applications, Research Application), End-User - Global Forecast 2024-2030

The dPCR & qPCR Market size was estimated at USD 8.05 billion in 2023 and expected to reach USD 8.88 billion in 2024, at a CAGR 10.23% to reach USD 15.94 billion by 2030.

Digital PCR (dPCR) refers to a measurement technique that provides an absolute quantification of target nucleic acids by partitioning the reaction. Quantitative PCR (qPCR), also known as real-time PCR, is a technique that enables the continuous monitoring of the PCR reaction as it progresses. It involves using fluorescent reporter molecules to quantify the amount of amplified nucleic acids in real-time. dPCR and qPCR enable rapid DNA amplification and quantification necessary for a wide range of applications, including genotyping, gene expression analysis, viral load determination, and validation of high-throughput sequencing data. The rising prevalence of infectious diseases has necessitated the deployment of advanced diagnostics procedures to ensure fast and efficient disease detection. Increased funding for genomics research projects from public & private organizations and the growing need for personalized diagnostics and therapeutic options has further boosted the adoption of PCR technologies. However, the initial investment for acquiring advanced instrumentation required for PCR can be a significant economic barrier for some organizations. Furthermore, analyzing high-dimensional data generated by dPCR & qPCR experiments requires specialized bioinformatics tools & the lack of expertise might impede the widespread adoption of dPCR and qPCR. Efforts by the government and established players to expand access to training programs for PCR technology can overcome such challenges. Technological advancements in PCR technologies and continuous research & development efforts have expanded the growth of dPCR and qPCR technology.

Regional Insights

In the Americas region, the demand for dPCR and qPCR is driven primarily by advancements in life sciences research, diagnostics, and pharmacogenomics. The United States has a well-established pharmaceutical industry that invests heavily in research & development activities. A strong focus on precision medicine initiatives also contributes to increased adoption. In Europe, there is an increasing number of diagnostic centers that frequently utilize advanced PCR technologies. Germany, France, and the UK also invest heavily in molecular diagnostics. Higher government spending on healthcare infrastructure and stringent regulations concerning food safety have driven the adoption of dPCR and qPCR in European nations. Rapidly growing economies in the APAC region, particularly China and India, are investing in their healthcare infrastructure to tackle the rising incidences of disease outbreaks and epidemics. Growing awareness about advanced molecular diagnostic platforms such as dPCR/qPCR among researchers, coupled with their increasing affordability, has contributed significantly towards their acceptance across the APAC region.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the dPCR & qPCR Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Rising prevalence of infectious diseases and genetic disorders
• Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
• Improving adoption in food testing procedures to ensure safety and consumption

Market Restraints

• High cost associated with dPCR and qPCR

Market Opportunities

• Technological advancements in PCR technologies
• Growing funding for genomics research projects worldwide

Market Challenges

• Technical limitations and data analysis complexities associated with dPCR and qPCR techniques

Market Segmentation Analysis

• Product: Expanding presence of sophisticated PCR instruments for rapid detection of genetic sequences
• Application: Utilization of dPCR and qPCR in clinical applications for infection monitoring and detection
• End-user: Rising focus of academic research and academic institutes toward PCR technologies

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the dPCR & qPCR Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the dPCR & qPCR Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

QIAGEN Expands Range of Digital PCR Kits and Services for the Biopharma Industry

QIAGEN is expanding its range of digital PCR (dPCR) kits and services for the biopharma industry. The new kits consist of a comprehensive portfolio of ready-to-use assays, reagents, and optimized protocols for high-throughput applications in drug development. They have been specifically designed to enhance data accuracy, sensitivity, reproducibility, and economic feasibility in various fields such as biology, genetics, and cancer research.

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited (Virax) announced an agreement for the distribution of Marburg Virus PCR testing kits. These kits are designed using real-time PCR technology and are capable of detecting RNA from the Marburg Virus.Given the highly virulent nature of Marburg Virus Disease, it is crucial to have accurate and reliable test kits to ensure optimal outcomes for affected individuals and to protect public health.

Thermo Fisher Scientific Launches New Digital PCR Automation Solution

Thermo Fisher Scientific introduced a cutting-edge automation solution for Digital PCR (dPCR) and quantitative PCR (qPCR) experiments. This innovative solution is specifically designed to enhance the accuracy, precision, and sensitivity of qPCR experiments, providing researchers with unparalleled results. The automated workstation included in the solution allows for the simultaneous processing of up to 48 samples, providing efficient and streamlined workflows. Additionally, the software-controlled temperature optimization and semi-automated reagent dispensing features ensure user convenience and ease of use.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the dPCR & qPCR Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the dPCR & qPCR Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, accela s.r.o., Agilent Technologies, Inc., Analytik Jena GmbH, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., BioMed Central Ltd, BioMérieux S.A., Canopy Biosciences, LLC, Combinati Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., GE Healthcare Inc., JN Medsys Pte. Ltd., Merck KGaA, PerkinElmer, Inc., Pfizer Inc., Promega Corporation, QIAGEN N.V. by Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers AG, Stilla Technologies SA, Takara Bio Inc., and Vela Diagnostics.

Market Segmentation & Coverage

This research report categorizes the dPCR & qPCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Instruments

Reagents & Consumables

Software & Services

Application

• Clinical Application
• Blood Screening
• Oncology Testing
• Pathogen Testing
• Forensic Applications
• Research Application
• End-User
• Academic Research & Institutes
• Contract Research Organizations
• Hospitals & Care Providers
• Pharmaceutical & Biotechnology Companies

Region

• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year